Lamitrin 50 mg (Tablet)

Unit Price: ৳ 18.05 (3 x 10: ৳ 541.50)
Strip Price: ৳ 180.50

Medicine Details

Product Title

Lamitrin Antiepileptic Drug

Categories

  • Antiepileptic
  • Bipolar Disorder Medication

Description

Phenyltriazine antiepileptic used to treat epilepsy and bipolar disorder by inhibiting voltage-sensitive sodium channels and stabilizing neuronal membranes.

Indications

  • Adjunctive therapy in partial-onset seizures
  • Adjunctive therapy in primary generalized tonic-clonic seizures
  • Adjunctive therapy in generalized seizures of Lennox-Gastaut syndrome
  • Monotherapy in patients aged 16 years and older with epilepsy
  • Treatment of bipolar disorder in patients aged 18 years and older

Pharmacology

  • Inhibits voltage-sensitive sodium channels
  • Stabilizes neuronal membranes
  • Modulates release of presynaptic excitatory neurotransmitters
  • Inhibits sodium currents
  • Binds to various receptors including serotonin 5-HT3, Adenosine A1/A2, α1/α2/β adrenergic, dopamine D1/D2, GABA A/B, histamine H1, κ-opioid, mACh, and serotonin 5-HT2 receptors

Dosage & Administration

  • Specific dosage escalation regimens for different age groups and co-administered medications
  • Usual maintenance doses for epilepsy and bipolar disorder
  • Initial weight-based dosing guide for pediatric patients taking Valproate for epilepsy

Interactions

  • Valproate increases Lamitrin concentrations
  • Carbamazepine, phenytoin, phenobarbital, primidone, and rifampin decrease Lamitrin concentrations
  • Estrogen-containing oral contraceptives decrease Lamitrin concentrations
  • Protease inhibitors lopinavir/ritonavir and atazanavir/ritonavir decrease Lamitrin exposure

Side Effects

  • Dizziness
  • Headache
  • Diplopia
  • Nausea
  • Blurred vision
  • Somnolence
  • Rash
  • Vomiting
  • Diarrhea
  • Infection
  • Fever
  • Abdominal pain
  • Tremor

Pregnancy & Lactation

Pregnancy Category C. Excreted in human milk. Decision should be made whether to discontinue nursing or discontinue the drug.

Precautions & Warnings

  • Discontinue at the first sign of rash
  • Monitor for blood dyscrasias
  • Monitor for suicidal behavior and ideation
  • Monitor for aseptic meningitis

Use in Special Populations

  • Safety and effectiveness in very young pediatric patients aged 1 to 24 months not demonstrated
  • Safety and effectiveness in pediatric patients aged 10 to 17 years not established

Overdose Effects

  • Ataxia
  • Nystagmus
  • Seizures
  • Decreased level of consciousness
  • Coma
  • Intraventricular conduction delay

Therapeutic Class

Primary anti-epileptic drugs

Storage Conditions

Keep out of reach of children. Store in a dry place below 25°C temperature and protected from light

Related Brands